{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:06:41Z","timestamp":1775797601076,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Reversible splenial lesion syndrome (RESLES) is a clinico-radiological syndrome characterized by a reversible lesion in the splenium of the corpus callosum. It is more common in children, and most patients recover completely with active treatment. However, recurrent RESLES is very rare and its etiology is unknown, posing significant challenges for clinicians in terms of prediction, diagnosis, and treatment. This article reports the first case of RESLES Type I in a young adult with five episodes and identifiable predisposing factors (intracranial infection and immunosuppressant dependence). By analyzing the patient\u2019s medical history, neuroimaging characteristics, body fluid test results, and response to immunomodulatory therapy, and reviewing recent literature on recurrent RESLES. The findings suggest that intracranial infection and immune dysfunction may be potential factors leading to the recurrence of RESLES Type I in this case, while serum sodium levels can remain within the normal range. Furthermore, we observed that infe cranial MRI lesions associated with RESLES in this patient often appeared 4\u20137 days after symptom onset, indicating a potential delay in imaging changes. Therefore, it is recommended that clinicians select appropriate timing for neuroimaging examinations and consider repeat scanning when necessary to reduce the risk of misdiagnosis or missed diagnosis.<\/jats:p>","DOI":"10.3389\/fmed.2026.1815607","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:25:25Z","timestamp":1775795125000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of recurrent RESLES type I: analysis of pathogenic factors and delayed imaging manifestations"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhihui","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang","place":["Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxun","family":"He","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang","place":["Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yunnan Qujing Central Hospital (Qujing First People\u2019s Hospital), Qujing","place":["Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang","place":["Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang","place":["Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang","place":["Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yunnan Qujing Central Hospital (Qujing First People\u2019s Hospital), Qujing","place":["Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunli","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang","place":["Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1552-6569.2008.00279.x","article-title":"Reversible splenial lesion syndrome (RESLES): what\u2019s in a name?","volume":"21","author":"Garcia-Monco","year":"2011","journal-title":"J Neuroimaging."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jns.2010.02.013","article-title":"Differences in the time course of splenial and white matter lesions in clinically mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS).","volume":"292","author":"Takanashi","year":"2010","journal-title":"J Neurol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/dmcn.16067","article-title":"International consensus definitions for infection-triggered encephalopathy syndromes.","volume":"67","author":"Sakuma","year":"2025","journal-title":"Dev Med Child Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12887-021-03097-x","article-title":"Clinical study of recurrent mild encephalitis\/encephalopathy with a reversible splenial lesion in two cases.","volume":"22","author":"Xue","year":"2022","journal-title":"BMC Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4103\/0028-3886.378683","article-title":"Recurrent mild Encephalitis\/encephalopathy with reversible splenial lesion.","volume":"71","author":"Xia","year":"2023","journal-title":"Neurol India."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1212\/01.wnl.0000144274.12174.cb","article-title":"Clinically mild encephalitis\/encephalopathy with a reversible splenial lesion.","volume":"63","author":"Tada","year":"2004","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.3390\/jcm14124169","article-title":"Clinical variability of pediatric MERS: insights from a retrospective observational study.","volume":"14","author":"Romeo","year":"2025","journal-title":"J Clin Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2169\/internalmedicine.4516-20","article-title":"Reversible splenial lesion syndrome with some novel causes and clinical manifestations.","volume":"59","author":"Lu","year":"2020","journal-title":"Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12883-017-0875-5","article-title":"Mild encephalitis\/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review.","volume":"17","author":"Yuan","year":"2017","journal-title":"BMC Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.braindev.2020.08.001","article-title":"Guidelines for the diagnosis and treatment of acute encephalopathy in childhood.","volume":"43","author":"Mizuguchi","year":"2021","journal-title":"Brain Dev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.braindev.2020.04.006","article-title":"Epidemiological changes of acute encephalopathy in Japan based on national surveillance for 2014-2017.","volume":"42","author":"Kasai","year":"2020","journal-title":"Brain Dev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.braindev.2011.04.004","article-title":"Oxidative stress in patients with clinically mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS).","volume":"34","author":"Miyata","year":"2012","journal-title":"Brain Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1192118","DOI":"10.3389\/fneur.2023.1192118","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy coexistent with reversible splenial lesion syndrome: a case report and literature review.","volume":"14","author":"Lin","year":"2023","journal-title":"Front Neurol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.3390\/ijms24097960","article-title":"Autoimmune neuroinflammatory diseases: role of interleukins.","volume":"24","author":"Khan","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e17982","DOI":"10.1097\/MD.0000000000017982","article-title":"Mild encephalitis\/encephalopathy with a reversible splenial lesion secondary to encephalitis complicated by hyponatremia: a case report and literature review.","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e01440","DOI":"10.1002\/brb3.1440","article-title":"Reversible lesion in the splenium of the corpus callosum.","volume":"9","author":"Tetsuka","year":"2019","journal-title":"Brain Behav."},{"key":"B17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease.","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1241549","DOI":"10.3389\/fneur.2023.1241549","article-title":"Reversible splenial lesion syndrome in children: a retrospective study of 130 cases.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Neurol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1815607\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:25:26Z","timestamp":1775795126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1815607\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":18,"alternative-id":["10.3389\/fmed.2026.1815607"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1815607","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1815607"}}